Whetstone Capital Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
5,329
-445
-8% -$19.9K 0.06% 65
2026
Q1
$278K Buy
5,774
+1,020
+21% +$47.6K 0.1% 30
2025
Q4
$230K Sell
4,754
-137
-3% -$6.79K 0.07% 31
2025
Q3
$231K Buy
+4,891
New +$236K 0.06% 42

Other funds holding SNY

Whetstone Capital Advisors's SNY Position: Q2 2026 in Review

Whetstone Capital Advisors reduced its Sanofi (SNY) stake by 7.7% in Q2 2026, selling an estimated $19.9K and leaving 5,329 shares worth $227K. The position accounts for 0.06% of the portfolio, ranked #65.

Whetstone Capital Advisors first reported a position in SNY in Q3 2025 and has held it in 4 quarters since. The position peaked at $278K in Q1 2026. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Whetstone Capital Advisors held 5,329 shares of Sanofi worth $227K as of Q2 2026.
  • Whetstone Capital Advisors sold 445 Sanofi shares in Q2 2026, an estimated $19.9K.
  • Sanofi made up 0.06% of Whetstone Capital Advisors's portfolio in Q2 2026, its #65 holding.
  • Whetstone Capital Advisors first reported a position in Sanofi in Q3 2025 and has held it in 4 quarters since.
  • Whetstone Capital Advisors's Sanofi position peaked at $278K in Q1 2026.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Whetstone Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.